Eckert & Ziegler acquires American cancer specialist
Eckert & Ziegler is now acquiring the division and hopes to remedy these shortcomings quickly so that it can resume delivery. The management expects to be able to win back customers who have migrated elsewhere as Biocompatibles has developed several innovations that improve the use of implants and has patented these unique solutions. By purchasing the division, Eckert & Ziegler will be able to offer these enhanced solutions to its European customers too. In the medium term, the Eckert & Ziegler Group intends to use Biocompatibles as an American distribution platform for its entire range of tumor irradiation products.
Most read news
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.